Subscription pricing
Support A recent study of 6,403 people showed that those treated with the drug pravastatin, one of the effects of which is to reduce cholesterol, had about one-third fewer nonfatal heart attacks and one-third fewer deaths from coronary disease than did those not taking the drug. ████ ██████ ██ ██████████ ████ █████ ████████ █████ ████ ████ █████ ███ ████ █████ ███████ █████ ████ ██████ ████ ███████ ███████████ ███████ ████ █████ ████ ████████ ███████████ ██████ ███████ ███ ████ ██ █████ ████████
Summarize Argument
The author concludes that lowering cholesterol reduces heart disease risk. She supports this with a study showing that people treated with pravastatin, which lowers cholesterol, had fewer heart attacks and heart disease deaths than people not taking the drug. She also notes that people with heart disease often have higher cholesterol levels.
Identify and Describe Flaw
This is the cookie-cutter flaw of mistaking correlation for causation. The author shows that high cholesterol and heart disease are correlated and assumes that high cholesterol causes heart disease risk.
Also, she thinks that pravastatin further proves this causation, assuming that it reduces the risk of heart disease by lowering cholesterol. But the drug could reduce heart disease risk in another way, and simply lower cholesterol as a side effect.
24.
The argument's reasoning is flawed ███████ ███ ████████
a
neglects the possibility ████ ███████████ ███ ████ ██████ ████ ███████
b
fails to consider ████ ███████████ ███ ██████ ███ ████ ██ █████ ███████ ███ ███ ██ █ ███████████ ██ ███ ████████ ███████████ ██████
c
relies on past █████████ ██████ ████ ███████ ███ █████████ ██████████ ████ ███ ████ █████ ██ ███ ████████ █████ █████
d
draws a conclusion █████████ ███ ███████ ██ ████████ ███████████ ██████ ██ █████ ████████ ████ ██ ████ ███ ██████████ ██████ █████ ██ ███ ████████ ███████ ███████████ ███ ███████████ ██████
e
fails to consider ████ ██████████ ██ ███ ███████ ██████████ █████ ██ ██████ ███████████